To determine if APR-246 and MQ can refold endogenous R175H mutant p53 in TOV-112D ovarian carcinoma cells, we treated the cells with APR-246 or MQ and performed co-immunostaining with PAb1620 and anti-p53 polyclonal antibody FL-393. The gene discussed is TP53; the disease is ovarian carcinoma.